Annual Conference Agenda

2018 Annual Education Conference Agenda

Thursday, October 4, 2018

TimeSession
7:00 am - 7:50 amRegistration & Breakfast
7:50 am - 8:00 am Welcome Conference Overview and Logistics
8:00 am - 9:00 am Opportunities for Assessment and Improvement in the
Quality of Cancer Care in the US

Larry Shulman, MD, FACP
Professor of Medicine
Deputy Director for Clinical Services
Director, Center for Global Cancer Medicine
Abramson Cancer Center-University of Pennsylvania

• Understand the close tie between data, quality
assessment and quality improvement
• Understand different sources of clinical and
financial data and how they interact and strengthen
quality work
• Understand quality at the local – hospital – level,
and what works and what doesn’t
• Understand how hospital registry data contributes
to the National Cancer Data Base, and how that drives
quality at both the hospital and national level.
9:00 am -10:00 amHepatocellular Carcinoma in 2018
Nikolaos Pyrsopoulos, MD, PhD, MBA
Chief, Division of Gastroenterology & Hepatology, Rutgers NJMS
Medical Director Liver Transplantation, University Hospital Professor
of Medicine, Rutgers NJMS
President Elect Faculty Organization, Rutgers NJMS

• Describe epidemiology of Hepatocellular carcinoma
• Describe etiology of Hepatocellular carcinoma
• Describe treatment modality
10:00 am -10:30 amBreak | Exhibit Hall Opens
10:30 am-11:30 amCurrent management of GI and Pancreatic
Neuroendocrine Tumors

Amand Laird, MD, FACS
Chief, Section of Endocrine Surgery, Rutgers Cancer Institute
of New Jersey; Associate Professor of Surgery, Rutgers Robert
Wood Johnson Medical School

• Describe staging and evaluation of neuroendocrine tumors
of the GI tract and pancreas
• Describe medical and surgical treatment of GI and pancreas
neuroendocrine tumors
11:30 am - 12:30 pm40 Years of Public Health Cancer Surveillance and
Research and the Implications of Quality Data

Antoinette M. Stroup, PhD
(co-presenting with Christina Tan, MD, MPH)
Director, Cancer Epidemiology Services and Associate
Professor, Rutgers School of Public Health/Rutgers Cancer
Institute of New Jersey

• Provide an overview of how the New Jersey State Cancer
Registry aids in public health awareness and cancer research.
• Discuss the significance of quality cancer data and
its impact on public health.
• Provide registrars with New Jersey State Cancer Registry
updates and the Department’s vision for the future.
12:30 pm - 1:15 pmLunch
1:15 pm - 2:00 pm ORANJ Business Meeting
2:00 pm - 3:00 pm CoC Survey Preparedness
Cindy Stern, RN, MSN, CCRP
Senior Administrator, Penn Cancer Network
University of Pennsylvania Abramson Cancer Center
• Identify strategies that will help your cancer program be prepared for a successful Commission on Cancer accreditation survey
• Discuss best practices that avoid common accreditation survey deficiencies
• Describe essential documentation requirements
3:00 pm - 4:00 pm SEER Summary Stage- What’s changed? A comparison
of SS 2000 and SS 2018

Heather Stabinsky, MS.Ed, CTR
Cancer Registry Information Specialist, New Jersey State
Cancer Registry/Rutgers CINJ

• Define SEER Summary Stage
• Provide an in-depth review of the revisions made to the
SEER Summary Stage Manual from 2000 to 2018
• Demonstrate the use of SS 2018 guidelines through
example cases
4:00 pmAdjournment
6:00 pm - 8:00 pmPresident's Reception

Friday, October 5, 2018

7:00 am - 8:00 amRegistration and Breakfast
8:00 am - 9:00 am8th Edition AJCC Staging for Lung Cancer
Maqsood Amjad, MD
Partner, Regional Cancer Care Associates
Clinical Assistant Professor, Rutgers’s Cancer Institute of
New Jersey

• Describe the definition of the Lung Primary Tumor changes.
• Describe the definition of Lung Distant Metastasis.
• Describe the AJCC prognostic Stage groups.
• Discuss PD-L1 marker and its’ importance in lung cancer.
9:00 am - 10:00 am2018 Solid Tumor Webinar
Jim Hofferkamp, BA, CTR
NAACCR

• Describe 2018 Solid Tumor Rules
10:00 am - 10:30 amBreak and Check-out
10:30 am - 11:30 amEndometrial Cancer: Updates in Surgical Staging
and Future Implications

Ruth Stephenson, DO, FACOG
Gynecologic Oncologist
Rutgers Cancer Institute of New Jersey

• Basic review of significance of endometrial cancer
• Standard operations/ Treatment Strategies based
on NCCN Guidelines
• New advances and techniques in staging and ACJJ
Update on Staging
11:30 am - 12:30 pm8th Edition of the American Joint Committee on Cancer:
Breast Cancer Staging and Coding Updates

Firas Eladoumikdachi, MD
Interim Section Chief, Breast Surgery, Division of Surgical
Oncology, Rutgers RWJMS. Director, Rutgers Cancer
Institute of New Jersey, at Hamilton

• Discuss the changes in the 8th Ed. AJCC breast cancer.
• Discuss the breast histologic changes. Review breast
Biomarkers prognostic factor for treatment of breast cancer.
• Update breast treatment coding.
12:30 pm - 2:00 pmInstallation Luncheon/Awards/Basket Raffles
2:00 pmAdjournment